These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27714817)

  • 41. The influence of vitamin E succinate on the stability of polyethylene oxide PEO controlled release matrix tablets.
    Shojaee S; Cumming I; Kaialy W; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():486-92. PubMed ID: 23880087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations.
    Devi S; Kumar S; Verma V; Kaushik D; Verma R; Bhatia M
    Drug Deliv Transl Res; 2022 Nov; 12(11):2693-2707. PubMed ID: 35178670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage forms.
    Khames A
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1335-43. PubMed ID: 23706099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study.
    Maggi L; Segale L; Torre ML; Ochoa ME; Conte U
    Biomaterials; 2002 Feb; 23(4):1113-9. PubMed ID: 11791914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photostability of extended-release matrix formulations.
    Maggi L; Ochoa Machiste E; Fasani E; Albini A; Segale L; Conte U
    Eur J Pharm Biopharm; 2003 Jan; 55(1):99-105. PubMed ID: 12551710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
    Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging.
    Tajiri T; Morita S; Sakamoto R; Suzuki M; Yamanashi S; Ozaki Y; Kitamura S
    Int J Pharm; 2010 Aug; 395(1-2):147-53. PubMed ID: 20580795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies.
    Karmarkar AB
    Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol.
    Varma M; Singla AK; Dhawan S
    Drug Dev Ind Pharm; 2004 May; 30(5):545-53. PubMed ID: 15244090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of effect of excipient source variation on rheological behavior of diltiazem HCl-HPMC wet masses using a mixer torque rheometer.
    Chatlapalli R; Rohera BD
    Int J Pharm; 2002 May; 238(1-2):139-51. PubMed ID: 11996818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of dissolution medium on the release of diltiazem hydrochloride from carbomeric matrices].
    Sedláková M; Rabisková M; Svajdlenka E
    Ceska Slov Farm; 2006 Mar; 55(2):65-71. PubMed ID: 16570583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S; Wang T; Grover R
    Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)].
    Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.